Associate Director - Investor Relations & Corporate Communications

February 1

Apply Now

Receive Emails with Similar Jobs

Iovance Biotherapeutics, Inc.

WebsiteLinkedInAll Job Openings

Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.

Immuno Oncology • Autologous Cell Therapy • Tumor Infiltrating Lymphocytes (TIL) • Novel Cancer Immunotherapies • cell therapy

501 - 1000 employees

Founded 2014

🧬 Biotechnology

💊 Pharmaceuticals

⚕️ Healthcare Insurance

📋 Description

• This position will support and execute an investor relations and corporate communications program to effectively convey Iovance’s mission, vision and values as the global leader in TIL cell therapy for solid tumor cancers. • This individual will execute and implement the corporate narrative, commercial launch story and pipeline messages to the investor audience across multiple communications channels. • They will work closely with investor and public relations leaders to foster shareholder relationships and effectively target the highest quality investors while supporting investor and industry conferences as well as non-deal road shows, manufacturing facility tours, KOL panels and other bespoke investor events. • This role will also include active monitoring of analyst research and media coverage to ensure message pull through and content accuracy. • This position will liaise with the clinical, advocacy, medical affairs and commercial functions on corporate and investor messaging around medical meetings and data milestones. • They will also help plan and organize key deliverables for the quarterly and annual reporting processes, in close collaboration with Finance and Legal.

🎯 Requirements

• Bachelor's or higher degree. • 8-10 years' experience in investor relations, Wall Street, public relations or corporate communications, preferably with at least 2 years of Investor Relations at a public commercial stage life science company. • Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics. • Deep expertise and a proven history of repeated successes in investor engagement and message implementation. • Prioritization and time management skills to juggle and complete multiple projects with strict attention to detail and sense of urgency, sometimes in a short timeframe. • Prior experience writing investor presentations, scripts and press releases, or other content for the biotech Wall Street audience, along with aptitude for working with the investment community. • Excellent verbal and written communication skills across multiple internal and external channels. • Ability to translate complex scientific and clinical information into simple, easy to comprehend messages.